Skip to main content
Premium Trial:

Request an Annual Quote

Toronto General Hospital Program Buys $880K in Thermo Proteomic Tools

NEW YORK (GenomeWeb News) — A Toronto General Hospital program has bought around CA$1 million ($880,000) worth of certain Thermo Electron technologies as part of an R&D and supply agreement, Thermo said late last week.
The company will also fund a postdoc for two years and offer training workshops for the program, which will study transplant rejection.
The Research in Immune Tolerance in Transplantation program at General Hospital’s Industrial Biodevelopment Laboratory has acquired a liquid chromatographer and mass spec, Thermo said.
The RITT will study the biology of transplant rejection and try to develop treatments to prevent it.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.